Mercator Medsystems, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
9
Ending by 2030
Sep 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Medical Instrument and Medical Method for Localized Drug Delivery (US 11,654,267) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 1 fee due Dec 23, 2026The maintenance fee for Intravascular Delivery of Nanoparticle Compositions and Uses Thereof (US 9,061,014) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Combination therapy for treatment of restenosis (US 11,813,249) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jun 1, 2027The maintenance fee for Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation (US 9,199,065) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
- 1 fee due Sep 3, 2027The maintenance fee for Combination therapy for treatment of restenosis (US 10,576,063) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Treatment of Restenosis Using Temsirolimus (US 10,617,678) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,691,080 | Dual modulus balloon for interventional procedures In force · From the USPTO record | In force | From the USPTO record | |
| US 8,721,590 | Dual modulus balloon for interventional procedures In force · From the USPTO record | In force | From the USPTO record | |
| US 8,016,786 | Dual modulus balloon for interventional procedures In force · From the USPTO record | In force | From the USPTO record | |
| US 9,789,276 | Dual modulus balloon for interventional procedures In force · From the USPTO record | In force | From the USPTO record | |
| US 10,561,816 | Dual modulus balloon for interventional procedures In force · From the USPTO record | In force | From the USPTO record | |
| US 9,011,879 | Treatment of Renal Hypertension or Carotid Sinus Syndrome with Heated Fluid Sympathetic Denervation or Neuromodulation In force · Medium confidence | In force | Medium confidence | |
| US 9,199,065 | Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation In force · From the USPTO record | In force | From the USPTO record | |
| US 11,083,877 | Treatment of hypertension by renal vascular delivery of guanethidine In force · From the USPTO record | In force | From the USPTO record | |
| US 8,465,752 | Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,258,565 | Intravascular Delivery of Nanoparticle Compositions and Uses Thereof In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 23: 4 lapsed for an unpaid fee · 8 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 4 abandoned · 25 no status recorded